Mycophenolate mofetil as an effective alternative to cyclosporin in post-transplant haemolytic uraemic syndrome.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2000-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/15.12.2064PMID 11096161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?

  1998cited by this paper
• Haemolytic-Uraemic Syndrome in a Renal Transplant Recipient Treated by Conversion to Mycophenolate Mofetil

  1998cited by this paper
• Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation.

  1997cited by this paper
• Hemolytic uremic syndrome in solid-organ transplant recipients

  1996cited by this paper
• [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].

  1994cited by this paper

• Pediatric kidney transplantation in India – The journey so far and the road ahead

  2014cites this paper
• Development and Validation of a Novel Dual Wavelength UV-Spectrophotometric Method for the Simultaneous Estimation of Mycophenolate Mofetil and Prednisolone

  2014cites this paper
• Mycophenolic Acid (Cellcept and Myofortic) Induced Injury of the Upper GI Tract

  2009cites this paper
• Tacrolimus-induced HUS: an unusual cause of acute renal failure in nephrotic syndrome

  2007cites this paper
• Conversion to sirolimus.

  2006cites this paper
• Mycophenolate mofetil as an alternative to cyclosporine in post renal transplant thrombocytopenia

  2004cites this paper
• Thrombotic microangiopathy after renal transplantation in the United States.

  2003cites this paper
• Fulminant recurrence of atypical hemolytic uremic syndrome during a calcineurin inhibitor‐free immunosuppression regimen

  2002cites this paper